Acute migraine headache. Cluster headache syndrome, unspecified
Conditions
Interventions
Intervention 1: Intervention group A: receiving interavenous paracetamol with a dose 1 gram .The length of the study period is one year and each drug is injected once. Intervention 2: Intervention gro
Sponsors
Birjand University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Not having a specific neurological disease No history of continuous use of drugs and long-term painkillers
Exclusion criteria
Exclusion criteria: pregnancy History of neurological disease Patients without personal consent Having a body temperature higher than37.7 degrees Celsius Having a diastolic blood pressure greater than 105 mm Hg Patients treated with systemic corticosteroids Allergy to dexamethasone, egg and soy Patients with a history of diabetes mellitus Active gastrointestinal ulcers Myocardial infarction in the previous week Hypokalemic familial paralysis (for dexamethasone) Continuous use of drugs and long-term painkillers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain reduction in acute migraine headache patients based on Visual pain measurement criteria. Timepoint: When the patient enters the study. Method of measurement: Visual pain measurement criteria. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHashem Mirbolooki
Birjand University of Medical Sciences
Outcome results
None listed